,15 Endothelin-1 and angiotensin II are key mediators of damage in FSGS and act in tandem through ETAR and the angiotensin II subtype 1 receptor (AT1R) to drive podocyte damage, inflammation, and sclerosis.16 Here, EDN1 is linked to focal segmental glomerulosclerosis.